Midazolam

Midazolam

The BNF recommends buccal midazolam as an emergency drug for the management of status epilepticus in dental practice.

Midazolam is a Schedule 3 controlled drug (CD). This means that:

• prescriptions or requisitions for midazolam must comply with the full CD regulations
• records of midazolam usage do not need to be kept in a CD register
• invoices for midazolam need to be retained for 2 years
• midazolam (as other Schedule 3 drugs) should be denatured before being placed in waste containers; see SDCEP Practice Support Manual⁸ (www.psm.sdcep.org.uk) for guidance on the denaturation of midazolam
• midazolam is exempt from the safe custody requirements and will not legally require storage in a CD cabinet

Information on the legal status of midazolam is shown in the section Controlled Drugs and Drug Dependence in general BNF guidance (available at www.medicinescomplete.com).